http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114839027-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8802a62cc6be74c76f2c45d05f799b31 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N1-30 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N1-30 |
filingDate | 2022-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c946ef48620281294701167360966377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_067fb49d2df6d5346e111c2d022fe26b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_425bed9f2691a04962b95e4db253f0e3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cddcc6e0ca61b6dee6986496994d4a02 |
publicationDate | 2022-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-114839027-A |
titleOfInvention | A kind of bone marrow decalcification composition, preparation method and use |
abstract | In order to solve the technical problem that the existing bone marrow decalcification solution is soaked for a long time when the bone marrow tissue is decalcified, the bone marrow tissue components are destroyed, the embodiment of the present invention provides a bone marrow decalcification composition, a preparation method and an application, the The decalcification composition is composed of components in the following mass fractions: HCl 5.0%-8%; formic acid 13%-15%; acetic acid 4.0-4.5%; the balance is neutral buffered formaldehyde solution. The preparation method includes: mixing pure components of HCl, formic acid, acetic acid and neutral buffered formalin to obtain a bone marrow decalcification composition; the embodiment of the present invention shortens the soaking time of the bone marrow tissue; improves the decalcification efficiency; The existing bone marrow decalcification solution to the bone marrow tissue after the decalcification of HE staining of the nucleus reddened, immunohistochemical antigen loss serious, low DNA concentration and other problems. |
priorityDate | 2022-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.